Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines.
The effectiveness of vaccination programs would be enhanced greatly through the availability of vaccines that can be administered simply and, preferably, painlessly without the need for timed booster injections. Tetanus is a prime example of a disease that is readily preventable by vaccination but remains a major threat to public health due to the problems associated with administration of the present vaccine. Here we show that a protective immune response against live Clostridium tetani infection in mice can be elicited by an adenovirus vector encoding the tetanus toxin C fragment when administered as a nasal or epicutaneous vaccine. The results suggest that these vaccination modalities would be effective needle-free alternatives. This is the first demonstration that absorption of a small number of vectored vaccines into the skin following topical application of a patch can provide protection against live bacteria in a disease setting.
Shi
Z
Z
Vaxin, Inc., USA.
Zeng
M
M
Yang
G
G
Siegel
F
F
Cain
L J
LJ
van Kampen
K R
KR
Elmets
C A
CA
Tang
D C
DC
D000256:Adenoviridae / Q000235:genetics*; D000279:Administration, Cutaneous; D000281:Administration, Intranasal; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D001428:Bacterial Vaccines / Q000008:administration & dosage* / Q000276:immunology; D001483:Base Sequence; D003017:Clostridium tetani / Q000276:immunology; D017931:DNA Primers; D005822:Genetic Vectors; D016133:Polymerase Chain Reaction; D013742:Tetanus / Q000517:prevention & control*
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D017931:DNA Primers